Evidence map›Paper›PMID 38482013›Full record

ArticleFrontiers in immunology2024

IL-6 signaling drives self-renewal and alternative activation of adipose tissue macrophages.

Jan Ackermann, Lilli Arndt, Janine Fröba, Andreas Lindhorst, Markus Glaß, Michaela Kirstein, Constance Hobusch, F Thomas Wunderlich, Julia Braune, Martin Gericke

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jan Ackermann *Institute of Anatomy, Leipzig University, Leipzig, Germany.
Lilli Arndt *Institute of Anatomy, Leipzig University, Leipzig, Germany.
Janine FröbaInstitute of Anatomy, Leipzig University, Leipzig, Germany.
Andreas LindhorstInstitute of Anatomy, Leipzig University, Leipzig, Germany.
Markus GlaßInstitute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Charles Tanford Protein Center, Halle (Saale), Germany.
Michaela KirsteinInstitute of Anatomy and Cell Biology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Constance HobuschInstitute of Anatomy, Leipzig University, Leipzig, Germany.
F Thomas WunderlichMax-Planck-Institute for Metabolism Research, Research Group for Obesity and Cancer, Cologne, Germany.
Julia Braune *Institute of Anatomy, Leipzig University, Leipzig, Germany.
Martin Gericke *Institute of Anatomy, Leipzig University, Leipzig, Germany.
Leipzig University · DEMartin Luther University Halle-Wittenberg · DEMax Planck Institute for Metabolism Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Obesity is associated with chronic low-grade inflammation of adipose tissue (AT) and an increase of AT macrophages (ATMs) that is linked to the onset of type 2 diabetes. We have recently shown that neutralization of interleukin (IL)-6 in obese AT organ cultures inhibits proliferation of ATMs, which occurs preferentially in alternatively activated macrophage phenotype. Methods: In this study, we investigated AT biology and the metabolic phenotype of mice with myeloid cell-specific IL-6Rα deficiency ( Results: Obese Discussion: Our results demonstrate IL-4Rα-independent anti-inflammatory effects of IL-6 on macrophages and the ability of IL-6 to maintain proliferation rates in obese AT.

Indexed as

Diabetes Mellitus, Type 2Interleukin-6Adipose TissueAnimalsInflammationMacrophagesMiceMice, KnockoutObesityInterleukin-6adipose tissue inflammationalternative activationdiabetesIL-6macrophagesmannose receptorobesityself-renewal

Identifiers

PMID38482013
PMCPMC10933059
OpenAlexW4392235694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.